Intellectual property

Capital A International, Owner of the Iconic AirAsia Brand, to be Publicly Listed in the U.S. through Business Combination with Aetherium Acquisition Corp

Retrieved on: 
Wednesday, February 28, 2024

CAPI leverages the expansion, management and licensing of the AirAsia brand, and serves as a dynamic global marketing catalyst for Asean brands.

Key Points: 
  • CAPI leverages the expansion, management and licensing of the AirAsia brand, and serves as a dynamic global marketing catalyst for Asean brands.
  • Tony Fernandes, Chief Executive Officer of Capital A said, “Over more than two decades, AirAsia has become a prestigious brand synonymous with value, innovation and inclusivity.
  • The evolution of the AirAsia brand has created a loyal global consumer base, positioning us favorably to expand our brand internationally through CAPI.
  • Under the terms of the proposed transaction, CAPI will combine with Aetherium and become a publicly traded entity.

Covalon Announces First Quarter Fiscal 2024 Results

Retrieved on: 
Wednesday, February 28, 2024

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.

Key Points: 
  • Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.
  • I am extremely proud of the progress that the Covalon team has made in the past few months with a solid focus on strengthening foundational elements for our business and setting the stage for substantial revenue growth in fiscal 2024.
  • In parallel with our intense focus on growth, we are also highly focused on streamlining our operating expenses relative to revenue, with the goal of achieving EBITDA profitability within fiscal 2024.
  • The entire Covalon team is very energized to drive Covalon into its forthcoming growth phase.

Wallbox Announces Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Wednesday, February 28, 2024

Any forward-looking statement that Wallbox makes in this press release speaks only as of the date of such statement.

Key Points: 
  • Any forward-looking statement that Wallbox makes in this press release speaks only as of the date of such statement.
  • Wallbox reports its financial information required in accordance with the International Financial Reporting Standards (“IFRS”).
  • Wallbox defines EBITDA as loss for the period before income tax credit, financial income, interest expenses, amortization and depreciation and share of profit of equity-accounted investees.
  • We compensate for these limitations by relying primarily on our IFRS results and using the Non-IFRS Measures only as supplemental measures.

Fish & Richardson Expands Life Sciences Industry Team with Addition of Louis Fogel and Shaun Van Horn

Retrieved on: 
Wednesday, February 28, 2024

Intellectual property law firm Fish & Richardson is pleased to welcome seasoned litigators Louis Fogel, Ph.D., and Shaun Van Horn.

Key Points: 
  • Intellectual property law firm Fish & Richardson is pleased to welcome seasoned litigators Louis Fogel, Ph.D., and Shaun Van Horn.
  • The pair, who are based in Chicago, join Fish’s Litigation Group and are members of the Life Sciences Industry Team.
  • View the full release here: https://www.businesswire.com/news/home/20240228410387/en/
    Fish & Richardson Principal Louis Fogel (Photo: Business Wire)
    “Louis and Shaun have an impressive record and deep market knowledge in life sciences litigation,” said Global Head of Litigation Corrin Drakulich.
  • “Fish has been a dominant force in life sciences litigation for decades, and I’m thrilled to join this distinguished group,” said Fogel.

Trinity Life Sciences Launches Brand Insights AI

Retrieved on: 
Wednesday, February 28, 2024

Trinity Life Sciences , a leader in global life sciences commercialization solutions, today launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research.

Key Points: 
  • Trinity Life Sciences , a leader in global life sciences commercialization solutions, today launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research.
  • Brand Insights AI represents the intersection of AI and our biopharma-specific market research expertise, combined to supercharge a brand’s insights.”
    Dr. Deshpande will be speaking on GenAI solution exploration at the upcoming Trinity Life Sciences Forum on AI on April 23, 2024.
  • “Trinity Brand Insights AI is an excellent example of a paradigm-shifting tool for brand and insights teams that uses the latest technology.
  • Brand Insights AI allows brand and insights teams to:
    Trinity is hosting an AI forum, Making AI Real: Lessons From the Frontlines , on April 23, 2024 at the Sheraton Commander Hotel in Cambridge, MA.

Husch Blackwell Launches Client-Driven Artificial Intelligence Practice Group

Retrieved on: 
Tuesday, February 27, 2024

National law firm Husch Blackwell is pleased to announce the launch of its Artificial Intelligence (AI) team, a cross-practice group of attorneys focused on representing clients in AI-related matters, including advising on new legal and regulatory frameworks governing AI and its risks.

Key Points: 
  • National law firm Husch Blackwell is pleased to announce the launch of its Artificial Intelligence (AI) team, a cross-practice group of attorneys focused on representing clients in AI-related matters, including advising on new legal and regulatory frameworks governing AI and its risks.
  • “This practice is in response to the tremendous interest and need of our clients.
  • Our interdisciplinary attorney practice group has been working closely with our data science team, which is one of the largest in the country, to bring our clients unmatched perspective and expertise,” said Megan Scheiderer , AI practice co-chair and commercial litigation and mass tort & products liability partner.
  • The group will work alongside Husch Blackwell’s data science team led by Chief Information Officer Blake Rooney .

Domain Therapeutics Promotes Stephan Schann as Chief Scientific Officer (CSO)

Retrieved on: 
Tuesday, February 27, 2024

Domain Therapeutics (“Domain” or “the Company”), a clinical-stage global biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announces the expansion of the Company’s executive management team with the appointment of Stephan Schann as Chief Scientific Officer (CSO).

Key Points: 
  • Domain Therapeutics (“Domain” or “the Company”), a clinical-stage global biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announces the expansion of the Company’s executive management team with the appointment of Stephan Schann as Chief Scientific Officer (CSO).
  • Stephan will oversee the development of Domain’s proprietary pipeline and its highly innovative R&D center based in Strasbourg, France.
  • Stephan has also contributed significantly to the Company’s scientific achievements and strategic direction.
  • Dr. Tony Johnson, President and Chief Executive Officer of Domain Therapeutics, said: “We are thrilled to have Stephan be promoted into the role of Chief Scientific Officer.

Global Nanocellulose Report 2024-2034: Focus on Cellulose Nanofibers, CelluloseNanocrystals and Bacterial Nanocellulose - ResearchAndMarkets.com

Retrieved on: 
Monday, February 26, 2024

The "Global Market for Nanocellulose (Cellulose Nanofibers, CelluloseNanocrystals, Bacterial Nanocellulose) 2024-2034" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Market for Nanocellulose (Cellulose Nanofibers, CelluloseNanocrystals, Bacterial Nanocellulose) 2024-2034" report has been added to ResearchAndMarkets.com's offering.
  • Despite being the most available natural polymer on earth, it is only over the past few years that cellulose has gained prominence as a nanostructured material, chiefly in the form of micro/nanofibrillar cellulose, nanocrystalline cellulose and bacterial nanocellulose.
  • As well as being completely renewable, safer to handle, and cheaper to produce, nanocellulose materials also possess exceptional physical and chemical properties.
  • The Global Market for Nanocellulose 2024-2034 provides an in-depth analysis of the global nanocellulose industry, encompassing cellulose nanofibers (CNF), cellulose nanocrystals (CNC), and bacterial nanocellulose (BNC).

Zcube Launches the 2024 Edition of Open Accelerator, an International Acceleration Program Aimed at Life Sciences Startups with Focus on Women's Health and Femtech

Retrieved on: 
Wednesday, February 28, 2024

Zcube - Zambon Research Venture announces the fifth edition of Open Accelerator, the international acceleration program for high-potential innovative startups in the field of life sciences.

Key Points: 
  • Zcube - Zambon Research Venture announces the fifth edition of Open Accelerator, the international acceleration program for high-potential innovative startups in the field of life sciences.
  • Starting this year, the program will focus on the femtech sector and will feature a new format.
  • The targeted therapeutic areas include gynecology, cardiovascular health, oncology, sexual health, endocrinology, gastroenterology, nutrition, autoimmune disorders, mental health, neurology, reproductive health, and more.
  • The Call for application will open on Friday, March 8, 2024, on the International Women's Day, and will remain open until June 16.

Artificial Intelligence (AI) and The Metaverse Overview and IP Perspective Online Course - ResearchAndMarkets.com

Retrieved on: 
Friday, February 23, 2024

Mark Weston is a partner at Hill Dickinson LLP where he is Head of Commercial Law (London), Information Technology Law and, Intellectual Property Law.

Key Points: 
  • Mark Weston is a partner at Hill Dickinson LLP where he is Head of Commercial Law (London), Information Technology Law and, Intellectual Property Law.
  • Mark's practice covers both non-contentious and contentious matters in all areas of commercial law, intellectual property law, information technology law, Internet, digital and privacy/data law.
  • He has extensive experience in-house, having been seconded in the past to Hewlett Packard and new technology companies.
  • Mark appears regularly on BBC1 (usually providing advice on-screen to BBC Watchdog) and also on Sky News as a legal commentator.